Ovarian Cancer Clinical Trials

Showing 601-620 of 902 trials

Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)

NCT02558348

The purpose of Part 1 (Phase 1b) is to evaluate the general safety and tolerability of repeated 21-day cycles of AL3818 therapy, and to reevaluate the maximum tolerated dose (MTD). The purpose of Part 2 (Phase 2a) is to evaluate the efficacy of repeated 21-day cycles of AL3818 therapy preliminary efficacy of AL3818 in subjects with recurrent or metastatic endometrial, ovarian or cervical cancer.

Endometrial CancerOvarian CancerCervical Cancer

Advenchen Laboratories, LLC12 participantsStarted Nov 2015

Chicago, Illinois, United States • Salt Lake City, Utah, United States

SUSPENDEDPhase 3

Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer

NCT01218490

It is a multicenter randomized trial of superior cleaning compared the absence of dissection in stage III patients with optimal surgical resection without retroperitoneal lymph node palpable.

Ovarian Cancer

Institut Cancerologie de l'Ouest450 participantsStarted Dec 2008

Amiens, France • Angers, France • Angers, France +16 more locations

Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)

Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer

Related Searches

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes

Advanced Methods for Cancer Detection by Vaginal Screening

Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Imaging Study in Advanced Ovarian Cancer

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer